Global Antisense & Rnai Therapeutics Market Size 2024, Forecast To 2033
11 Mar, 2024
The antisense & RNAi therapeutics market has seen rapid growth, surging from $1.59 billion in 2023 to $1.77 billion in 2024, with a compound annual growth rate (CAGR) of 11.4%. This expansion in the historic period is attributed to increased funding, technological advancements, rising healthcare expenditure, a growing elderly population, and economic growth in emerging markets. Projecting into 2028, the market is poised for rapid growth, reaching $2.81 billion with a CAGR of 12.3%. Anticipated growth drivers include improved healthcare access, a surge in cancer prevalence, and increased demand for antisense and RNAi therapeutics due to the impact of COVID-19. Key trends in the forecast period involve focusing on research and development for orphan diseases, utilizing nanoparticles, and collaborative efforts for product innovation.
Global Antisense & RNAi Therapeutics Market Key Driver
The antisense & RNAi therapeutics market is expected to witness increased demand due to the rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases. Gene suppression approaches, including RNA interference and antisense oligonucleotides, are employed in treating various neurodegenerative conditions by repairing mutant genes. Notably, Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases globally, affecting millions of people. In the USA, approximately 6.2 million people may have Alzheimer’s disease, and as of January 2023, around 500,000 people are diagnosed with Parkinson’s disease. The growing prevalence of these neurodegenerative diseases, along with infectious diseases, is expected to propel the growth of the antisense & RNAi therapeutics market.
Get A Free Sample Of The Global Antisense & RNAi Therapeutics Market ReportGlobal Antisense & RNAi Therapeutics Market Segments
The antisense & rnai therapeutics market covered in this report is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
By Geography:The regions covered in the antisense & rnai therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
North America was the largest region in the antisense & RNAi therapeutics market in 2023. The regions covered in the antisense & rnai therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Antisense & RNAi Therapeutics Industry Players
Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical
Get The Full Global Antisense & RNAi Therapeutics Market Report
Antisense & RNAi Therapeutics Market Overview
Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs.
Antisense & RNAi Therapeutics Global Market Report 2023 provides data on the global antisense & rnai therapeutics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The antisense & rnai therapeutics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.